Determination of calcium level in plasma, serum and urine is used for monitoring and as an aid in the diagnosis of clinical conditions associated with hypocalcemia and hypercalcemia. Increase in calcium concentration occurs in endocrine disorders such as primary hyperparathyroidism, hyperthyroidism, adrenal insufficiency and in malignant neoplasms. Low calcium level can occur in cirrhosis, nephrotic syndrome, hypoparathyroidism, hypothyroidism, in dialysis patients, and tetany. The test is used to monitor the effectiveness of calcium supplementation in patients with osteoporosis.
Specification
Specimen serum, plasma, urine
On board stability up to 10 weeks
Calibration stability up to 4 days
Measuring range 0,2-20 mg/dl
Regulatory status CE IVD